| Model Number |
364499 |
| Medical Device Problem Code |
Device Dislodged or Dislocated (2923)
|
| Health Effect - Clinical Code |
No Consequences Or Impact To Patient (2199)
|
| Date of Event |
12/20/2019
|
|
Type of Reportable Event
|
Malfunction
|
|
Event or Problem Description
|
|
An orsiro drug-eluting stent system was chosen to treat a severely calcified lesion (80 percent stenosis degree) in the rca.The device could not be advanced due to vessel tortuosity.A guidezilla was used.During advancing the orsiro, resistance was felt and the device was removed.Then, it was detected that the stent was shifted to the shaft area.
|
| |
|
Additional Manufacturer Narrative
|
|
The returned product was subjected to a technical analysis and the corresponding production documentation was reviewed to establish whether a deviation from the manufacturing process could be the cause for this event.The technical investigation of the returned instrument revealed that the balloon is well folded and shows no signs of inflation.Stent imprints are visible on the balloon surface, indicating that the stent was initially crimped centered on the balloon.The stent was returned separately and is severely deformed.Review of the production documentation confirmed that the instrument was manufactured according to specifications and passed all in-process and final inspections.As a part of final inspection every stent system undergoes visual inspection to ensure correct embedding and homogeneous crimping of the stent.Further, the stent outer diameter is verified to 100 percent and the stent retention force of a defined amount of samples is tested from every lot.Based on the conducted investigations, no manufacturing or material related root cause could be determined.It should be noted that the ifu clearly states that pre-dilatation is mandatory and warns against re-insertion.
|
| |
|
Search Alerts/Recalls
|